<DOC>
	<DOCNO>NCT00001067</DOCNO>
	<brief_summary>To determine drug efficacy safety HIV-infected patient treat zidovudine ( AZT ) versus stavudine ( d4T ) versus drug . Also , compare short- long-term change magnitude HIV RNA time . Asymptomatic patient CD4 count 300 cells/mm3 likely tolerate nucleoside analog . d4T , favorable toxicity profile demonstrate anti-HIV activity previous study , provide additional therapeutic option .</brief_summary>
	<brief_title>The Effectiveness Three Anti-HIV Drug Combinations HIV-Infected Patients Who Have Never Used Anti-HIV Drugs</brief_title>
	<detailed_description>Asymptomatic patient CD4 count 300 cells/mm3 likely tolerate nucleoside analog . d4T , favorable toxicity profile demonstrate anti-HIV activity previous study , provide additional therapeutic option . Patients randomize receive d4T alone , AZT alone , combination least 12 week . After week 12 , 3TC add combination arm . Treatment continue 48 week ( total 48 week , amend 3/26/96 ) .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Required : TMP / SMX , aerosolize pentamidine , dapsone PCP prophylaxis . Allowed : Atovaquone . IV pentamidine . TMP / SMX . Trimetrexate . Trimethoprimdapsone . Clindamycinprimaquine . Topical antifungal . Clotrimazole . Ketoconazole . Fluconazole . Amphotericin B. Itraconazole . Rifabutin . Isoniazid . Pyrazinamide . Clofazimine . Clarithromycin . Azithromycin . Ethambutol . Amikacin . Ciprofloxacin . Ofloxacin . Pyrimethamine . Sulfadiazine . Clindamycin . Filgrastim ( GCSF ) . Up 1000 mg/day acyclovir . Erythropoietin . Antibiotics . Antipyretics . Analgesics . Antiemetics . Rifampin . Concurrent Treatment : Allowed : Local radiation therapy . Patients must : HIV infection . CD4 count 300 600 cells/mm3 . NO history AIDS . NO active opportunistic infection . NO prior nucleoside therapy . Life expectancy least 2 year . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Serious underlie medical condition HIV life expectancy le 2 year . Malignancy require systemic cytotoxic chemotherapy . Active grade 2 bad peripheral neuropathy . Concurrent Medication : Excluded : Antiretrovirals study drug . Systemic cytotoxic chemotherapy . Foscarnet . Patients follow prior condition exclude : Chronic diarrhea define three stool per day 15 day , within 30 day prior study entry . Unexplained temperature &gt; = 38.5 C 7 day within 30 day prior study entry . Active participation experimental therapy within 30 day prior study entry . Prior Medication : Excluded : Prior nucleoside antiretrovirals 1 week long duration . Any antiretroviral within 90 day prior study entry . Nonnucleoside reverse transcriptase inhibitor protease inhibitor within 30 day prior study entry . Biologic response modifier IL2 interferon within 30 day prior study entry .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
	<keyword>Stavudine</keyword>
	<keyword>Lamivudine</keyword>
</DOC>